Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells

Blood

Volumn 111, Issue 9, 2008, Pages 4542-4550

  Fens, Marcel H A M ^a   Mastrobattista, Enrico ^a   De Graaff, Anko M ^b   Flesch, Frits M ^a   Ultee, Anton ^c   Rasmussen, Jan T ^d   Molema, Grietje ^e   Storm, Gert ^a   Schiffelers, Raymond M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CD51 ANTIGEN; CYTOCHALASIN D; GLYCINE; LACTADHERIN; PHOSPHATIDYLSERINE; MEMBRANE ANTIGEN; MILK PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL AGING; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MELANOMA CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR BLOOD FLOW; ANIMAL; CATTLE; CELL CULTURE; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; EXPERIMENTAL MELANOMA; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ERYTHROCYTE AGING; ERYTHROCYTES; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MILK PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PHAGOCYTOSIS;

EID: 47149091674     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-06-094763     Document Type: Article

References (37)

1. Grimsley C, Ravichandran KS. Cues for apoptotic cell engulfment: eat-me, don't eat-me and comeget-me signals. Trends Cell Biol. 2003;13:648-656.
2. Wu Y, Tibrewal N, Birge RB. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol. 2006;16:189-197.
3. Hoffmann PR. deCathelineau AM. Ogden CA, et al. Phosphatidylserine (PS) induces PS receptormediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol. 2001;155:649-659.
4. Stubbs JD, Lekutis C, Singer KL, et al. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci U S A. 1990; 87:8417-8421.
5. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature. 2002;417:182-187.
6. Akakura S. Singh S. Spataro M, et al. The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res. 2004;292:403-416.
7. Andersen MH, Graversen H. Fedosov SN, Petersen TE, Rasmussen JT. Functional analyses of two cellular binding domains of bovine lactadherin. Biochemistry. 2000;39:6200-6206.
8. Ren Y, Savill J. Apoptosis: the importance of being eaten. Cell Death Differ. 1998;5:563-568.
9. Asano K. Miwa M, Miwa K, et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med. 2004;200:459-467.
10. Hanayama R. Tanaka M. Miyasaka K, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004; 304:1147-1150.
11. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature. 1990;343:170-173.
12. Hu P, Yan J, Sharifi J. Bai T Khawli LA, Epstein AL. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis. Cancer Res. 2003;63:5046-5053.
13. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
14. Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999;103:1227-1230.
15. Silvestre JS, Thery C, Hamard G, et al. Lactadherin promotes VEGF-dependent neovascularization. Nat Med. 2005;11:499-506.
16. Hvarregaard J, Andersen MH, Berglund L, Rasmussen JT, Petersen TE. Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur J Biochem. 1996;240:628-636.
17. Coller BS, Springer KT Beer JH, et al. Thromboerythrocytes: in vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J Clin Invest. 1992:89:546-555.
18. Kok RJ, Schraa AJ, Bos EJ, et al. Preparation and functional evaluation of RGD-modified proteins as alpha(v) beta(3) integrin directed therapeutics. Bioconjug Chem. 2002;13:128-135.
19. Temming K, Meyer DL, Zabinski R, et al. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels. Bioconjug Chem. 2006;17:1385-1394.
20. Neutzner M, Lopez T, Feng X, Bergmann-Leitner ES, Leitner WW, Udey MC. MFG-E8/lactadherin promotes tumor growth in an angiogenesis-dependent transgenic mouse model of multistage carcinogenesis. Cancer Res. 2007;67:6777-6785.
21. Rossi L, Serafini S. Pierige F, et al. Erythrocytebased drug delivery. Expert Opin Drug Deliv. 2005;2:311-322.
22. Desai AG, Thakur ML. Radiolabeled blood cells: techniques and applications. Crit Rev Clin Lab Sci. 1986;24:95-122.
23. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A. 1998;95:3077-3081.
24. Aderem A Phagocytosis and the inflammatory response. J Infect Dis. 2003;187(suppl 2):S340-S345.
25. Araki N. Johnson MT Swanson JA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol. 1996;135:1249-1260.
26. Schrijvers DM, Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM. Flow cytometric evaluation of a model for phagocytosis of cells undergoing apoptosis. J Immunol Methods. 2004; 287:101-108.
27. Balla J, Vercellotti GM, Nath K, et al. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant. 2003; 18(suppl 5):v8-v12.
28. Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin Cancer Res. 2004;10:415-427.
29. Davis PD, Dougherty GJ. Blakey DC, et al. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Res. 2002;62:7247-7253.
30. Tozer GM, Kanthou C, Baguley BC. Disrupting tumour blood vessels. Nat Rev Cancer. 2005;5:423-435.
31. Ceriani RL, Sasaki M, Sussman H, Wara WM, Blank EW. Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci U S A. 1982;79:5420-5424.
32. Muzykantov VR, Sakharov DV, Smirnov MD, Samokhin GP, Smirnov VN. Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. Biochim Biophys Acta. 1986; 884:355-362.
33. Smirnov VN, Domogatsky SP, Dolgov VV, et al. Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A. 1986:83:6603-6607.
34. Oka K, Sawamura T, Kikuta K, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A. 1998; 95:9535-9540.
35. Magnani M, Rossi L, D'Ascenzo M, Panzani I, Bigi L, Zanella A. Erythrocyte engineering for drug delivery and targeting. Biotechnol Appl Bio-chem. 1998;28(pt1):1-6.
36. Kumar A, Eckman JR, Wick TM. Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides. Am J Hematol. 1996;53:92-98.
37. Eda S, Lawler J, Sherman IW. Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein. Mol Biochem Parasitol. 1999;100:195-205.